Par Equity

Neuranics is a company focused on developing advanced magnetic sensors integrated with semiconductor technology for applications in health, fitness, and the metaverse. Their proprietary technology is designed to detect minute magnetic impulses produced by the body's organs, utilizing scalable spintronics sensors. This innovative approach aims to address the limitations of current health monitoring devices and enhance human-machine interfaces. By leveraging magnetic sensing, Neuranics seeks to improve the interaction with the central, peripheral, and autonomic nervous systems, as well as muscles, thereby offering significant advancements for healthcare companies in creating next-generation wearable and implantable devices.

Neuranics is a company focused on developing advanced magnetic sensors integrated with semiconductor technology for applications in health, fitness, and the metaverse. Their proprietary technology is designed to detect minute magnetic impulses produced by the body's organs, utilizing scalable spintronics sensors. This innovative approach aims to address the limitations of current health monitoring devices and enhance human-machine interfaces. By leveraging magnetic sensing, Neuranics seeks to improve the interaction with the central, peripheral, and autonomic nervous systems, as well as muscles, thereby offering significant advancements for healthcare companies in creating next-generation wearable and implantable devices.

StretchSense specializes in sensor-based technology for capturing hand motion data, focusing on the development of innovative performance capture gloves known as MoCap Pro gloves. These gloves utilize advanced stretch sensor technology, allowing for accurate and comfortable hand tracking. They incorporate soft capacitors that respond to stretching and squeezing, measuring these changes with precision. The gloves work seamlessly with various industry-leading software platforms such as Maya, Unreal Engine, and Unity, as well as with optical systems like OptiTrack, Qualisys, and Vicon. By integrating machine learning with their hardware, StretchSense provides animators, game developers, and film studios with the tools needed for lifelike animations and enhanced performance capture capabilities.

TriVirum, Inc. is a medical device company based in Lisburn, United Kingdom, that specializes in the development of wearable sensors designed to enhance patient health outcomes. Incorporated in 2020, the company leverages edge semiconductor and signal processing technology to create innovative, cost-effective medical-quality sensors. These devices provide clinicians with actionable information, enabling them to make informed decisions that improve patient care while also reducing costs for health plans. TriVirum aims to deliver impactful healthcare solutions on a global scale.

TriVirum, Inc. is a medical device company based in Lisburn, United Kingdom, that specializes in the development of wearable sensors designed to enhance patient health outcomes. Incorporated in 2020, the company leverages edge semiconductor and signal processing technology to create innovative, cost-effective medical-quality sensors. These devices provide clinicians with actionable information, enabling them to make informed decisions that improve patient care while also reducing costs for health plans. TriVirum aims to deliver impactful healthcare solutions on a global scale.

BrainWaveBank has developed a first-in-class wearable electroencephalography (EEG) device to conveniently and non-invasively measure the mechanisms that underpin neurological disorders and therapies. Our platform can securely gather, store and analyse data from many thousands of users, building neurocognitive profiles of individuals and populations or demographic groups. This easy-to-scale and distributable approach will help clinical professionals to transform our understanding of brain health and develop the next generation of treatments. BrainWaveBank was founded in January 2015 and has offices in Belfast , Northern Ireland and Dublin, Ireland.

Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.

BrainWaveBank has developed a first-in-class wearable electroencephalography (EEG) device to conveniently and non-invasively measure the mechanisms that underpin neurological disorders and therapies. Our platform can securely gather, store and analyse data from many thousands of users, building neurocognitive profiles of individuals and populations or demographic groups. This easy-to-scale and distributable approach will help clinical professionals to transform our understanding of brain health and develop the next generation of treatments. BrainWaveBank was founded in January 2015 and has offices in Belfast , Northern Ireland and Dublin, Ireland.

Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.

Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.

BrainWaveBank has developed a first-in-class wearable electroencephalography (EEG) device to conveniently and non-invasively measure the mechanisms that underpin neurological disorders and therapies. Our platform can securely gather, store and analyse data from many thousands of users, building neurocognitive profiles of individuals and populations or demographic groups. This easy-to-scale and distributable approach will help clinical professionals to transform our understanding of brain health and develop the next generation of treatments. BrainWaveBank was founded in January 2015 and has offices in Belfast , Northern Ireland and Dublin, Ireland.

Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.

Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.

Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.

Current Health help healthcare reduces risk & cost by monitoring, managing, and engaging patients at home.